0001193125-26-123492
SEC filingGenesco Inc. (GCO) reported net sales of $2.44 billion for fiscal year 2026 ended January 31, 2026, as per its 10-K filing dated March 25, 2026. Gross margin stood at $1.13 billion after cost of sales of $1.31 billion. Selling and administrative expenses totaled $1.10 billion, with no goodwill impairment and asset impairments and other, net of -$8.1 million, yielding operating income of $17.3 million. Other components of net periodic benefit cost added $625K, while interest expense net was -$4.1 million (net of $0.7 million interest income). Earnings from continuing operations before taxes were $12.6 million, bolstered by a $685K income tax benefit, resulting in $13.3 million earnings from continuing operations. Net earnings were $13.3 million, or $1 per basic and diluted share (10.4 million basic shares, 10.6 million diluted). The balance sheet reflects total assets of $1.39 billion, including $105.4 million cash and equivalents, $433.9 million inventories, and $618.5 million current assets. Total liabilities were $825.9 million, with long-term debt at only $3.4 million and equity at $567.0 million. Cash flows showed $145.8 million from operations, -$62.1 million investing (capital expenditures $62.1 million), and -$13.3 million financing, with a $71.4 million net increase in cash. These figures highlight operational resilience and strong liquidity, supporting strategic flexibility amid retail dynamics.
Genesco Inc. (GCO) achieved net sales of $2.44 billion for FY2026 ended January 31, 2026. Gross margin was $1.13 billion, following cost of sales of $1.31 billion. Selling and administrative expenses reached $1.10 billion, goodwill impairment was $0, and asset impairments and other, net were -$8.1 million, resulting in operating income of $17.3 million. Earnings from continuing operations before income taxes totaled $12.6 million after other benefit cost of $625K and net interest expense of $4.1 million. A tax benefit of -$685K led to $13.3 million earnings from continuing operations. Discontinued operations contributed -$7K net of tax, for net earnings of $13.3 million, or $1 per basic share (10.4 million shares) and $1 per diluted share (10.6 million shares). No prior year comparative figures are provided in the XBRL data. Total assets stood at $1.39 billion, with equity at $567.0 million. (152 words)
Net sales for FY2026 were $2.44 billion. The provided filing content and XBRL data do not disclose segment breakdowns, geographic mix, or specific growth drivers. No detailed revenue composition is available in the excerpted MD&A or financial statements. (48 words)
Gross margin was $1.13 billion on $2.44 billion net sales. Operating income of $17.3 million followed $1.10 billion in selling and administrative expenses. No explicit margin percentages or prior period comparisons are stated. Asset impairments and other, net provided a -$8.1 million benefit, with no goodwill impairment. Share-based compensation was $12.2 million in cash flow adjustments. Cost structure reflects significant SG&A relative to sales. (78 words)
Net cash from operating activities was $145.8 million, including net income $13.3 million, depreciation and amortization $53.3 million, impairment of long-lived assets $4.4 million, and working capital changes such as inventories +$1.2 million and prepaids -$62.3 million. Investing activities used $62.1 million, all capital expenditures. Financing used $13.3 million, including $12.6 million share repurchases and net revolving facility activity of +$2.7 million. Effect of FX +$1.0 million; net cash increase $71.4 million. Balance sheet: current assets $618.5 million (cash $105.4 million, inventories $433.9 million), total assets $1.39 billion; current liabilities $376.3 million, total liabilities $825.9 million (long-term debt $3.4 million), equity $567.0 million. (128 words)
The provided MD&A excerpt from Item 7 does not include management guidance, strategic priorities, or specific risk factors beyond referencing the Consolidated Financial Statements. No forward-looking statements are disclosed in the available content. (42 words) (Total: 448 words)